Add high-sensitivity rapid COVID testing to your practice.

Offer accurate PCR-quality COVID testing to your practice and generate more revenue with a lower per-test cost than other molecular tests.

Get PCR-quality results at a fraction of the time & cost.

UOL COVID-19 Test utilizes patented molecular chemistry to provide PCR-quality results within 40 minutes, at a lower cost than other molecular tests. Approved by FDA.

96.1% Accuracy

96.1% Accuracy with no false positives when compared to a highly-sensitive PCR test. Learn more

PCR Sensitivity

NAATs can detect COVID up to 4 days earlier than antigen tests Learn more

Result in 40 minutes

As soon as 12 minutes for positive results.
Negative results in 40 minutes.

5-minute Setup

Anterior nasal swab sample collection, set up and run a test in under 5 minutes.

Powerful Detection

Detect all VOCs including Delta, BA.1, BA.2, BA.4, and BA.5. Analytical sensitivity over 20,000x higher than some commercially-available rapid antigen tests.

Tech Enabled

Our DxPro mobile app automatically interprets data with clear-text results. Patient registration, SMS result delivery, and automated reporting are available*.

*requires additional software integration, contact sales for more info.

  • UOL COVID-19 Test System

  • UOL COVID-19 Instrument

  • UOL COVID-19 Test Kit

  • DxPro App*

Loop-de-Loop™ RT-LAMP

A new test for the new normal.

The UOL COVID-19 Test uses a new, patented chemistry, the Loop-de-Loop™ RT-LAMP. Ideal for detection of infectious disease, with the power of PCR without complex equipment.

The result? Lower costs while maintaining accuracy.

Supported by leading institutions and investors.

Uh-Oh Labs is developing diagnostic tests through our Loop-de-Loop™ platform which enables simplicity, speed, and lower costs while providing accurate, lab-grade results.

We are led by a team of experts in molecular diagnostics and bioengineering and are supported by the National Institute of Health’s Rapid Acceleration of Diagnostics (RADx) initiative and private investors, including Y Combinator.

Accessible testing for all healthcare providers.

New services in pharmacies

Rapid results for primary care

Lower costs at rapid test sites

News & Updates